202 related articles for article (PubMed ID: 31540291)
1. Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms.
Carbonell D; Suárez-González J; Chicano M; Andrés-Zayas C; Triviño JC; Rodríguez-Macías G; Bastos-Oreiro M; Font P; Ballesteros M; Muñiz P; Balsalobre P; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540291
[TBL] [Abstract][Full Text] [Related]
2. Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations.
Chicano M; Carbonell D; Suárez-González J; Lois S; Ballesteros-Culebras M; Andrés-Zayas C; Muñiz P; Rodríguez-Macias G; Bastos-Oreiro M; Font P; Ballesteros M; Kwon M; Anguita J; Díez-Martín JL; Buño I; Martínez-Laperche C
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203905
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
Aguilera-Diaz A; Vazquez I; Ariceta B; Mañú A; Blasco-Iturri Z; Palomino-Echeverría S; Larrayoz MJ; García-Sanz R; Prieto-Conde MI; Del Carmen Chillón M; Alfonso-Pierola A; Prosper F; Fernandez-Mercado M; Calasanz MJ
PLoS One; 2020; 15(1):e0227986. PubMed ID: 31978184
[TBL] [Abstract][Full Text] [Related]
4. Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia.
Haferlach T
Hematol Rep; 2020 Sep; 12(Suppl 1):8957. PubMed ID: 33042506
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
6. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation DNA Sequencing-Based Gene Panel for Diagnosis and Genetic Risk Stratification in Onco-Hematology.
Gargallo P; Molero M; Bilbao C; Stuckey R; Carrillo-Cruz E; Hermosín L; Pérez-López O; Jiménez-Velasco A; Soria E; Lázaro M; Carbonell P; Yáñez Y; Gómez I; Izquierdo-García M; Valero-García J; Ruiz C; Such E; Calabria I
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454892
[TBL] [Abstract][Full Text] [Related]
8. Panel-based next-generation sequencing facilitates the characterization of childhood acute myeloid leukemia in clinical settings.
Ishida H; Iguchi A; Aoe M; Nishiuchi R; Matsubara T; Keino D; Sanada M; Shimada A
Biomed Rep; 2020 Nov; 13(5):46. PubMed ID: 32934818
[TBL] [Abstract][Full Text] [Related]
9. The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice.
Northrup V; Maybank A; Carson N; Rahmeh T
Am J Clin Pathol; 2020 Apr; 153(5):639-645. PubMed ID: 31875888
[TBL] [Abstract][Full Text] [Related]
10. Improved Variant Detection in Clinical Myeloid NGS Testing by Supplementing a Commercial Myeloid NGS Assay with Custom or Extended Data Filtering and Accessory Fragment Analysis.
Schejbel L; Novotny GW; Breinholt MF; El Fassi D; Schöllkopf C; Hogdall E; Nørgaard P
Mol Diagn Ther; 2021 Mar; 25(2):251-266. PubMed ID: 33687704
[TBL] [Abstract][Full Text] [Related]
11. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
12. Application of Newly Customized Myeloid NGS Panel in the Diagnosis of Myeloid Malignancies.
Alkhatabi HA; Alqahtani W; Alsolami R; Elaimi A; Hazzazi MS; Almashjary MN; Alkhatabi HA; Alghuthami ME; Daous YM; Yasin EB; Barefah A
Int J Gen Med; 2024; 17():37-48. PubMed ID: 38204493
[TBL] [Abstract][Full Text] [Related]
13. Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.
Balagopal V; Hantel A; Kadri S; Steinhardt G; Zhen CJ; Kang W; Wanjari P; Ritterhouse LL; Stock W; Segal JP
PLoS One; 2019; 14(10):e0224097. PubMed ID: 31658273
[TBL] [Abstract][Full Text] [Related]
14. Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.
Alonso CM; Llop M; Sargas C; Pedrola L; Panadero J; Hervás D; Cervera J; Such E; Ibáñez M; Ayala R; Martínez-López J; Onecha E; de Juan I; Palanca S; Martínez-Cuadrón D; Rodríguez-Veiga R; Boluda B; Montesinos P; Sanz G; Sanz MA; Barragán E
J Mol Diagn; 2019 Mar; 21(2):228-240. PubMed ID: 30576870
[TBL] [Abstract][Full Text] [Related]
15. Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.
King RL; Bagg A
Methods Mol Biol; 2017; 1633():1-17. PubMed ID: 28735477
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients.
Montaño A; Hernández-Sánchez J; Forero-Castro M; Matorra-Miguel M; Lumbreras E; Miguel C; Santos S; Ramírez-Maldonado V; Fuster JL; de Las Heras N; García-de Coca A; Sierra M; Dávila J; de la Fuente I; Olivier C; Olazabal J; Martínez J; Vega-García N; González T; Hernández-Rivas JM; Benito R
J Pers Med; 2020 Sep; 10(3):. PubMed ID: 32967112
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.
Press RD; Eickelberg G; Froman A; Yang F; Stentz A; Flatley EM; Fan G; Lim JY; Meyers G; Maziarz RT; Cook RJ
Am J Hematol; 2019 Aug; 94(8):902-912. PubMed ID: 31124175
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing-based panel testing for myeloid neoplasms.
Kuo FC; Dong F
Curr Hematol Malig Rep; 2015 Jun; 10(2):104-11. PubMed ID: 25933675
[TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.
Maes B; Willemse J; Broekmans A; Smets R; Cruys B; Put N; Madoe V; Janssen M; Soepenberg O; Bries G; Vrelust I; Achten R; Van Pelt K; Buvé K; Theunissen K; Peeters V; Froyen G
Int J Lab Hematol; 2017 Dec; 39(6):604-612. PubMed ID: 28722833
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing for genetic testing of familial colorectal cancer syndromes.
Simbolo M; Mafficini A; Agostini M; Pedrazzani C; Bedin C; Urso ED; Nitti D; Turri G; Scardoni M; Fassan M; Scarpa A
Hered Cancer Clin Pract; 2015; 13(1):18. PubMed ID: 26300997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
